Qingdao Saber Technology Pharma QST
Retatrutide
Finnrick tested 1 sample of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Qingdao Saber Technology Pharma QST on 29 May 2025. With fewer than 2 tests, a Finnrick rating of X (Unrated) was awarded.
Finnrick Rating™
Qingdao Saber Technology Pharma QST
Retatrutide
Tested 1 Sample
Last test 29 May 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Qingdao Saber Technology Pharma QST
Samples are tested in commercial labs
Tests Count
1
Scores
AVGMINMAX
Last
29 May 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 29 May 2025 | View | 20mg | 20.200mg | +1.0% | 99.62% | (no batch ID) | No Label / Silver Crimp / Yellow Cap | Lab | Public | |